New OECD country cancer profile for Sweden in collaboration with IHE
By annette
The report puts a spotlight on the disease burden, cancer prevention, early detection, and the sustainability of cancer care systems. Läs mer
By annette
The report puts a spotlight on the disease burden, cancer prevention, early detection, and the sustainability of cancer care systems. Läs mer
By annette
How good is cancer care in Lithuania compared to other EU countries and what can be improved? This dashboard-style report provides a visual and quantitative description of selected performance indicators in all areas of cancer care. It focuses specifically on women’s cancers (breast cancer and gynecological cancers). The purpose of the dashboard is to encourage …
By annette
In our latest Insight, Managing Director Peter Lindgren reflects on AI and health economics. There was no doubt about what was one of the big themes of the year at this year’s ISPOR meeting in Barcelona: AI. Although none of the plenary sessions were about exactly this, there were more than ten sessions on AI …
By annette
IHE’s Thomas Hofmarcher recently traveled to Dubai to present at the conference “Roadmap of Lung Cancer Prevention Program”, organized by the UAE MOHAP and MSD. More and more countries are looking to implement lung cancer screening programs, and the UAE is no exception. At the conference national and international experts exchanged ideas and experiences. Thomas …
By annette
IHE participated in the 6th edition of the European Cancer Forum in Brussels. Thomas Hofmarcher participated in a panel discussion on the “Quality of Life” pillar of the Europe’s Beating Cancer Plan. Of all four pillars, this pillar has received the least attention and EU-funded research projects. Is this because we don’t really know how …
By annette
How good is access to cancer medicines in Italy, and what can other European countries learn from it? A new dashboard-style report provides an in-depth analysis of Italy’s access to innovative cancer medicines, focusing on the Fund for Innovative Drugs (Fondo per i Farmaci Innovativi). The report reveals that Italy performs well in a European …
By annette
IHE was recently in Milan to celebrate the 30th birthday of EUROPA DONNA – The European Breast Cancer Coalition. To honor the great work done by EUROPA DONNA, Thomas Hofmarcher gave a presentation on European trends in breast cancer epidemiology and innovations. Successful patient advocacy rests on evidence-based research. At IHE, we work with national …
By annette
Germany’s national cancer plan was launched in 2008 with the aim to improve oncology care in the country. In order to inspire and enrich the discussion about an update of the plan, the German branch of All.Can International organized a workshop in Berlin to shed light on international experiences. Thomas Hofmarcher presented a dashboard-style comparison …
By annette
IHE is attending and also presenting two posters at the ISPOR Europe Conference next week. Our Managing Director Peter Lindgren, Chief Operating Officer Ann-Louise Tidell and Senior Research Manager Magnus Värendh will be looking forward to meeting up with old and new customers for project discussions. Poster presentations: 1. Swedish Allergists’ View on the Role …
By annette
A new study from IHE has recently been published in two articles that provides additional insights into the ultra-rare disease arginase 1 deficiency (ARG1-D). This is a metabolic disease which may cause spastic paraplegia, cognitive deficiency, seizures, and ultimately severe disability. In a European survey study of 21 individuals with ARG1-D, it was shown that …